At NeuroMetrix, we believe that technology can empower people to reclaim their lives from chronic disease. Through our long-standing history and clinical expertise, we understand that by tapping into the power of the nervous system, we can detect, diagnose and alter diseases without the side effects of drugs. Our mission is to improve health through technology – by investing in meaningful innovation and gathering data, we can use these insights to transform medicine.
NeuroMetrix was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. We are a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world.
We offer the millions of people who suffer from chronic pain with a wearable technology option for pain control that utilizes advanced neurostimulation. Our Quell® technology is an advanced system to relieve leg, foot and knee pain. Quell is more than a wearable device to relieve chronic pain. It is a patented system designed to help people reclaim their lives and get back to things and people they love.
We provided physicians all over the world with the ability to rapidly test for peripheral neuropathies at the point-of-care using our DPNCheck® and ADVANCE™ platforms. Neuropathies are diseases of the nerve that affect tens of millions of people in the U.S. and hundreds of millions around the world. Common neuropathies include diabetic peripheral neuropathy and Carpal Tunnel Syndrome.
The benefits of diagnostic and therapeutic devices are greatly enhanced when they are paired with sophisticated office based, mobile and cloud software. We invest in development of software accessories for our devices, including the Quell Relief mobile app, the Quell Apple Watch® app, the Quell Health Cloud® - one of the worlds largest chronic pain outcomes databases, and Reporter™ for local and enterprise installations of DPNCheck®.